SNHG21
gene geneOn this page
Also known as SCARNA15HGFSD2-AS1RP11-752G15.6
Summary
SNHG21 (small nucleolar RNA host gene 21, HGNC:50284) is a long non-coding RNA gene on chromosome 15q25.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50284 |
| Approved symbol | SNHG21 |
| Name | small nucleolar RNA host gene 21 |
| Location | 15q25.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | SCARNA15HG, FSD2-AS1, RP11-752G15.6 |
| Ensembl gene | ENSG00000250988 |
| Ensembl biotype | lncRNA |
| Entrez | 100505616 |
| RNAcentral | URS000075A784 — lncRNA, 810 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 17 lncRNA, 1 retained_intron
ENST00000544685, ENST00000558174, ENST00000558687, ENST00000559366, ENST00000561107, ENST00000607520, ENST00000715383, ENST00000834480, ENST00000834481, ENST00000834482, ENST00000834483, ENST00000834484, ENST00000834485, ENST00000834486, ENST00000834487, ENST00000834488, ENST00000834489, ENST00000834490
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000544685 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004251967 | 82750564 | 82750848 |
| ENSE00004251968 | 82754629 | 82757206 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 89.83.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.7110 / max 57.4145, expressed in 1541 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 148102 | 4.7110 | 1541 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.83 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.70 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.34 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.17 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.17 | gold quality |
| cerebellum | UBERON:0002037 | 84.09 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.07 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.71 | gold quality |
| muscle of leg | UBERON:0001383 | 83.55 | gold quality |
| putamen | UBERON:0001874 | 83.34 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 82.81 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.71 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.66 | gold quality |
| caudate nucleus | UBERON:0001873 | 82.54 | gold quality |
| pituitary gland | UBERON:0000007 | 82.49 | gold quality |
| right frontal lobe | UBERON:0002810 | 82.23 | gold quality |
| brain | UBERON:0000955 | 82.16 | gold quality |
| adenohypophysis | UBERON:0002196 | 82.02 | gold quality |
| temporal lobe | UBERON:0001871 | 81.92 | gold quality |
| amygdala | UBERON:0001876 | 81.87 | gold quality |
| cerebral cortex | UBERON:0000956 | 81.65 | gold quality |
| right ovary | UBERON:0002118 | 81.34 | gold quality |
| right uterine tube | UBERON:0001302 | 81.22 | gold quality |
| Ammon’s horn | UBERON:0001954 | 81.20 | gold quality |
| frontal cortex | UBERON:0001870 | 81.09 | gold quality |
| left ovary | UBERON:0002119 | 80.85 | gold quality |
| hypothalamus | UBERON:0001898 | 80.68 | gold quality |
| substantia nigra | UBERON:0002038 | 80.50 | gold quality |
| prefrontal cortex | UBERON:0000451 | 80.48 | gold quality |
| ovary | UBERON:0000992 | 80.46 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.40 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.